Some media reports have made Direct Primary Care seem like a practice that will burden primary care physicians and cause a workforce shortage that traditional family medicine practices will not cause, but the American Academy of Family Physicians is trying to dispel that myth.
Eli Lilly and Co. subsidiary Elanco US Inc. has completed the acquisition of the U.S. feline, canine and rabies vaccines portfolio from Boehringer Ingelheim Vetmedica Inc. and its manufacturing/research and development site.
Advising health care facilities nationwide of possible safety defects in battery-operated mobile medical carts, the U.S. Food and Drug Administration recently issued a warning accompanied by guidance from its headquarters in Silver Spring, Maryland.
In a revised approach to its plan with Arena Pharmaceuticals Inc. dating to November 2013, Eisai Inc. recently agreed to purchase all development and marketing rights for Arena’s weight loss treatment medication, lorcaserin hydrochloride CIV.
Access to coverage and records; changes in Medicare, and issues arising from opioid use, prescription costs, and regulatory changes lead the coming year’s list of biggest challenges to medical practitioners, the AMA said recently.
Revealing evidence of certain gaps in patient safety education for residents and fellows nationwide, a recent American Medical Association report highlights the need to clarify both definitions and procedures for the benefit of practitioners in training.
The House of Representatives’ Energy & Commerce Committee recently endorsed a quartet of bills designed to advance public health in Washington, D.C., all sponsored by Republican Representatives and passed unanimously by the 114th Congress.
Stakeholders and the public can hear a live webcast of Pfizer’s conference call planned for 10 a.m. EST on Jan. 31 featuring investment analysts and, additionally, access Pfizer’s 2016 fourth-quarter performance report online.
To streamline global operations, enhance productivity and position itself for growth, Eli Lilly and Co. recently revealed various personnel and structural adjustments to better align the Indianapolis-based pharmaceutical firm with desired outcomes.
Block grants to states with fewer strings attached to cover health care subsidies is a pragmatic and practical short-term solution in lieu of entirely ripping up and repealing the Affordable Care Act entirely, one policy analyst has proposed.
Without federal reform and changes to health care incentives, New York's Medicaid system will continue to be a bloated burden to other states, a researcher from a free market-oriented education think tank said during a recent interview.
The backlog in Medicare appeals will hopefully improve thanks to a final rule released by the Department of Health and Human Services last week that allows attorney adjudicators to hear appeals in some cases instead of administrative law judges.